33.000
+6,45%
2026-10-09
Fundamental Analysis
93 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +390.7% | +289.0% | 3 / 3 | +58.0% | +5.62 pp | +8.01 pp | +15.1% | 0.00 | 14.67 | 25,0 | +58,0% | 2,8 | +449,6% | 14.67 | 25.14 | −41,6% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 33.000 (close price on 2026-10-09)EPS (TTM): 2.250
Financial charts
1.Revenue & growth
VND bn25,0Q2/26
1.Revenue & growth
VND bn25,0Q2/26
2.Profit & growth
VND bn2,81Q2/26
3.Profit mix (Penman)
VND bn8,04Q2/26
4.Margins & cost structure
%13.9%Q2/26
5.Returns & cash cycle
% · days18.9%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn55,8Q2/26
8.Funding & debt health
VND bn · times55,8Q2/26
9.Revenue backlog
VND bn1,28Q2/26
10.Valuation
times · %15,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.041Q2/26
Adjusted EPS growth, latest quarter
450%
Average adjusted EPS growth, 3 quarters
225%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26